Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for clues to improve MSI colon cancer care

NCT ID NCT05511688

First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 29 times

Summary

This study follows 637 people with a specific type of colorectal cancer called MSI. Researchers want to find biological markers that can predict how the cancer will behave and whether chemotherapy will help. The goal is to better understand this cancer type and guide treatment decisions, not to test a new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CH

    Abbeville, France

  • CH

    Angoulême, France

  • Ch - Centre Hospitalier de Bézier

    Béziers, France

  • Ch - Ght Unyon Auxerre

    Auxerre, France

  • Ch - Hôpital Henri Duffaut

    Avignon, France

  • Ch - Hôpital Victor Dupouy

    Argenteuil, France

  • Chu - Hôpital Hôtel Dieu

    Angers, France

  • Chu - Hôpital Jean Minjoz

    Besançon, France

  • Chu - Hôpital Sud

    Amiens, France

  • Chu Poitiers

    Poitiers, VIENNE, 86021, France

  • Privé - Clinique Tivoli

    Bordeaux, France

  • Privé - Institut Du Cancer Avignon Provence

    Avignon, France

  • Privé - Polyclinique Bordeaux Nord

    Bordeaux, France

  • Privé- Centre Pierre Curie

    Beuvry, France

Conditions

Explore the condition pages connected to this study.